[HTML][HTML] COVID-19 outbreak in Daegu City, Korea and response to COVID-19: how have we dealt and what are the lessons?

SW Kim - Journal of Korean Medical Science, 2022 - ncbi.nlm.nih.gov
The first coronavirus disease 2019 (COVID-19) outbreak in Daegu city was overcome by
efforts, including; 1) prompt isolation and quarantine action by local government with …

维持性血液透析患者新型冠状病毒感染和死亡的危险因素分析

黄力, 李川, 董建华, 杨茜, 吴边, 葛永纯 - 肾脏病与透析肾移植杂志, 2023 - njcndt.com
目的: 观察维持性血液透析(MHD) 患者新型冠状病毒感染(COVID-19) 的临床特征,
分析患者进展为重型/危重型和死亡的危险因素. 方法: 回顾性观察2022-12-01~ 2023-02-01 …

Clinical features of COVID-19 among patients with end-stage renal disease on hemodialysis in the context of high vaccination coverage during the omicron surge …

NS Beck, S Song, T Park, SH Hong, J Jeong-Eun… - BMC nephrology, 2023 - Springer
Background We determined the clinical presentation and outcomes of the Omicron variant of
severe acute respiratory syndrome coronavirus 2 infection in hemodialysis patients and …

[HTML][HTML] Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for …

BA Khan, M Pagsinohin, LM Lu, P Tan, R Teo - Cureus, 2023 - ncbi.nlm.nih.gov
Introduction: Hemodialysis patients are deemed to be immunosuppressed and may not be
able to mount an adequate response to vaccination against the SARS-CoV-2 virus. Due to …

[HTML][HTML] Antibody response to COVID-19 vaccination in patients on chronic hemodialysis

H Choi, S Han, JS Kim, B Park, MJ Lee… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Purpose Since patients on hemodialysis (HD) are known to be vulnerable to coronavirus
disease 2019 (COVID-19), many studies were conducted regarding the effectiveness of the …

[HTML][HTML] Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis

YK Kee, HC Park, SJ Yoon, S Yu, E Ko… - Kidney Research and …, 2024 - ncbi.nlm.nih.gov
Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (COVID-19), there are lack of effective and proven treatments for …

Clinical outcomes of COVID-19 in hemodialysis patients

L Adwan, T Al-Sadi, S Shawakha… - Frontiers in Medicine, 2023 - frontiersin.org
Background The coronavirus disease 2019 (COVID-19) is known for its effects on the
respiratory system. Three years after the pandemic morbid and mortal consequences …

[HTML][HTML] COVID-19 incidence and outcomes among patients with kidney replacement therapy

S Changsirikulchai, P Sangthawan… - Kidney Research and …, 2023 - ncbi.nlm.nih.gov
Background We aimed to investigate the incidence, fatality, and associated factors in
patients with hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KT) …

[HTML][HTML] Acquired antineutrophil cytoplasmic antibody-associated glomerulonephritis after COVID-19 infection

JY Lee, HS Hwang - Kidney Research and Clinical Practice, 2023 - ncbi.nlm.nih.gov
On admission to our clinic, laboratory findings revealed a serum creatinine level of 2.46
mg/dL. Urinalysis showed microscopic hematuria; further, the urinary protein to creatinine …

Incorporation of chest computed tomography quantification to predict outcomes for patients on hemodialysis with COVID-19

H Xing, S Gu, Z Li, X Wei, L He, Q Liu, H Feng, N Wang… - 2024 - karger.com
Incorporation of chest computed tomography quantification to predict outcomes for patients on
hemodialysis with COVID-19 Page 1 Kidney Dis , DOI: 10.1159/000539568 Received: March …